Clinical Trial: Randomized Clinical Trial to Evaluate the Efficacy and Safety of SUBMO(R) as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07448129) titled 'Randomized Clinical Trial to Evaluate the Efficacy and Safety of SUBMO(R) as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.' on Feb. 26.

Brief Summary: The SUBMO-PIC01-2025 study evaluates whether SUBMO(R), a submucosal injection hydrogel composed of high-molecular weight hyaluronic acid and methylene blue, is as effective and safe as normal saline for endoscopic resection of superficial colorectal lesions larger than 10 mm. Its primary aim is to determine non-inferiority in complete resection rates, whether en bloc or fragmented, and to assess safety through the systematic identificati...